HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shun-Ichi Ariizumi Selected Research

Hepatocellular Carcinoma (Hepatoma)

5/2022Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment.
1/2022Improved Mortality, Morbidity, and Long-Term Outcome After Anatomical Hepatectomy With the Glissonean Pedicle Approach in Patients With Hepatocellular Carcinoma: 30 Years' Experience at a Single Institute.
5/2020A patient with post-Fontan operation underwent left hepatectomy and caudate lobectomy for hepatocellular carcinoma: a case report.
10/2019Diabetes Mellitus and/or Nonalcoholic Steatohepatitis-related Hepatocellular Carcinoma Showed Favorable Surgical Outcomes After Hepatectomy.
4/2019Cavo-atrial thrombectomy prior to hepatectomy for hepatocellular carcinoma with tumor thrombus in the right atrium: a case report.
1/2019A staged approach with initial tumor thrombectomy followed by hepatectomy for icteric-type hepatocellular carcinoma: A case report.
11/2013Lymphatic vessel endothelial hyaluronan receptor-1 is a novel prognostic indicator for human hepatocellular carcinoma.
3/2013Impact of hepatectomy for huge solitary hepatocellular carcinoma.
1/2007Sectionectomy is suitable for patients with T2 hepatocellular carcinoma according to the modified international union against cancer TNM Classification.
1/2005Step classification is useful for the determination of indications for systematized hepatectomy in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shun-Ichi Ariizumi Research Topics

Disease

12Neoplasms (Cancer)
04/2019 - 01/2002
10Hepatocellular Carcinoma (Hepatoma)
05/2022 - 01/2005
5Cholangiocarcinoma
03/2022 - 08/2011
3Non-alcoholic Fatty Liver Disease
09/2020 - 10/2019
3Hemorrhage
04/2019 - 01/2004
2Neoplasm Metastasis (Metastasis)
03/2022 - 08/2011
2Hyperphagia (Overeating)
11/2020 - 05/2018
2Obesity
11/2020 - 05/2018
2Fatty Liver
11/2020 - 05/2018
2Insulin Resistance
09/2020 - 05/2018
2Carcinogenesis
01/2016 - 05/2012
2Carcinoma (Carcinomatosis)
06/2014 - 01/2002
1Lymphatic Metastasis
03/2022
1Fibrosis (Cirrhosis)
09/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
05/2020
1Alcoholic Hepatitis
10/2019
1Diabetes Mellitus
10/2019
1Pulmonary Embolism
04/2019
1Cardiac Sudden Death (Sudden Cardiac Arrest)
04/2019
1Ventricular Fibrillation
04/2019
1Thrombosis (Thrombus)
04/2019
1Turner Syndrome (Turner's Syndrome)
01/2019
1Liver Cell Adenoma (Hepatocellular Adenoma)
01/2019
1Infections
05/2018
1Herpes Zoster
05/2018
1Hepatomegaly
05/2018
1Dysbiosis
05/2018
1Liver Neoplasms (Liver Cancer)
05/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2002
1Papillary Adenocarcinoma
01/2002
1Alcoholism (Alcohol Abuse)
01/2002
1Ductal Carcinoma
01/2002
1Chronic Pancreatitis
01/2002

Drug/Important Bio-Agent (IBA)

2LipopolysaccharidesIBA
11/2020 - 05/2018
2ChromatinIBA
05/2018 - 05/2012
1Tyrosine Kinase InhibitorsIBA
05/2022
1Estradiol (Delestrogen)FDA LinkGeneric
11/2020
1LeptinIBA
09/2020
1MyostatinIBA
09/2020
1LipidsIBA
12/2019
1ConnectinIBA
12/2019
1Biomarkers (Surrogate Marker)IBA
12/2019
1Heparin (Liquaemin)FDA LinkGeneric
04/2019
1Oral ContraceptivesIBA
01/2019
1Contraceptive Agents (Contraceptives)IBA
01/2019
1BilirubinIBA
01/2019
1Mitochondrial DNA (mtDNA)IBA
05/2018
1Tight Junction ProteinsIBA
05/2018
1AdipokinesIBA
05/2018
1chenodeoxycholate sulfate conjugate (CDCS)IBA
01/2018
1Untranslated RNA (Noncoding RNA)IBA
01/2016
1Hyaluronic Acid (Hyaluronan)IBA
11/2013
1Indicators and Reagents (Reagents)IBA
11/2013
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
03/2013
1CarbohydratesIBA
08/2011
1AntigensIBA
08/2011
1MucinsIBA
01/2002

Therapy/Procedure

14Hepatectomy
03/2022 - 01/2004
2Therapeutics
05/2022 - 03/2022
2Thrombectomy
04/2019 - 01/2019
1Immunotherapy
03/2022
1Adjuvant Chemotherapy
03/2022
1Fontan Procedure (Fontan Operation)
05/2020
1Cardiopulmonary Bypass (Heart-Lung Bypass)
04/2019
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2019
1Segmental Mastectomy (Lumpectomy)
01/2019
1Pancreaticoduodenectomy
01/2002